Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (1): 1-6.doi: 10.3736/jcim20100101
• Commentary • Next Articles
| [1] |
Paul A . Nonalcoholic fatty liver disease[J]. N Engl J Med, 2002,346(16):1221-1231
doi: 10.1056/NEJMra011775 |
| [2] | Brunt EM . Nonalcoholic steatohepatitis[J]. Semin Liver Dis, 2004,24(1):3-20 |
| [3] |
Bloomgarden ZT . American Association of Clinical Endocrinologists(AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC[J]. Diabetes Care, 2003,26(3):933-939
doi: 10.2337/diacare.26.3.933 |
| [4] |
Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L, Bolondi L . Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance[J]. Gut, 2004,53(7):1020-1023
doi: 10.1136/gut.2003.027086 |
| [5] |
Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Alemán JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR . Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis[J]. Cell Metab, 2008,7(2):125-134
doi: 10.1016/j.cmet.2007.11.013 |
| [6] |
Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS . Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults[J]. Arch Intern Med, 2004,164(19):2169-2175
doi: 10.1001/archinte.164.19.2169 pmid: 15505132 |
| [7] |
Wada J . Vaspin: a novel serpin with insulin-sensitizing effects[J]. Expert Opin Investig Drugs, 2008,17(3):3272-3273
doi: 10.1517/13543784.17.3.327 pmid: 18321232 |
| [8] |
Ye J . Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle[J]. Endocr Metab Immune Disord Drug Targets, 2007,7(1):65-74
doi: 10.2174/187153007780059423 |
| [9] |
Allison ME, Wreghitt T, Palmer CR, Alexander GJ . Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population[J]. J Hepatol, 1994,21(6):1135-1139
doi: 10.1016/S0168-8278(05)80631-2 |
| [10] |
Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J , O’Rahilly S, Shore S, Tom BD, Alexander GJ.Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection[J]. Hepatology, 1999,30(4):1059-1063
doi: 10.1002/(ISSN)1527-3350 |
| [11] |
Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP . Association of diabetes mellitus and chronic hepatitis C virus infection[J]. Hepatology, 1999,29(2):328-333
doi: 10.1002/hep.510290235 pmid: 9918906 |
| [12] |
Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A . Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection[J]. Mayo Clin Proc, 2000,75(4):355-359
doi: 10.4065/75.4.355 |
| [13] |
Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M.Thomas DL . Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States[J]. Ann Intern Med, 2000,133(8):592-599
doi: 10.7326/0003-4819-133-8-200010170-00009 |
| [14] |
Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL . Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B[J]. Gut, 2009,58(1):111-117
doi: 10.1136/gut.2008.157735 pmid: 18832522 |
| [15] |
Maylin S, Martinot-Peignoux M, Moucari R, Boyer N, Ripault MP, Cazals-Hatem D, Giuily N, Castelnau C, Cardoso AC, Asselah T, Féray C, Nicolas-Chanoine MH, Bedossa P, Marcellin P . Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C[J]. Gastroenterology, 2008,135(3):821-829
doi: 10.1053/j.gastro.2008.05.044 pmid: 18593587 |
| [16] |
Tabaru A, Narita R, Hiura M, Abe S, Otsuki M . Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a[J]. Am J Gastroenterol, 2005,100(4):862-867
doi: 10.1111/ajg.2005.100.issue-4 |
| [17] |
Park SH, Kim DJ, Lee HY . Insulin resistance is not associated with histologic severity in nondiabetic, noncirrhotic patients with chronic hepatitis B virus infection[J]. Am J Gastroenterol, 2009,104(5):1135-1139
doi: 10.1038/ajg.2009.6 |
| [18] |
Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS . Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis[J]. J Gastroenterol Hepatol, 2008,23(5):679-681
doi: 10.1111/j.1440-1746.2008.05361.x pmid: 18410599 |
| [19] |
Machado MV, Cortez-Pinto H . Insulin resistance and steatosis in chronic hepatitis C[J]. Ann Hepatol, 2009,8(Suppl 1):S67-S75
doi: 10.1152/ajpgi.90298.2008 pmid: 19381127 |
| [20] | Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P . Hepatitis C virus-associated hypobeta-lipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis[J]. Am J Gastroenterol, 2003,98(5):1150-1154 |
| [21] |
Demelia L, Civolani A, Murgia D, Murru A, Sorbello O, Rizzetto M . Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency[J]. J Hepatol, 2007,46(1):171-173
doi: 10.1016/j.jhep.2006.10.003 |
| [22] |
Grasso A, Malfatti F, Leo PD, Martines H, Fabris P, Toscanini F, Anselmo M, Menardo G . Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin[J]. J Hepatol, 2009,51(6):984-990
doi: 10.1016/j.jhep.2009.07.008 |
| [23] |
Thomopoulos KC, Theocharis GJ, Tsamantas AC, Siagris D, Dimitropoulou D, Gogos CA, Labropoulou-Karatza C . Liver steatosis is an independent risk factor for treatment failure in patients with chronic hepatitis C[J]. Euro J Gastroenterol Hepatol, 2005,17(2):149-153
doi: 10.1097/00042737-200502000-00004 |
| [24] |
Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K . Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection[J]. Cancer, 2003,97(12):2948-2950
doi: 10.1002/(ISSN)1097-0142 |
| [25] |
Castéra L, Hézode C, Roudot-Thoraval F, Lonjon I, Zafrani ES, Pawlotsky JM, Dhumeaux D . Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis[J]. Gut, 2004,53(3):420-424
doi: 10.1136/gut.2002.009936 |
| [26] |
Fan JG . Research on fatty liver disease in 2008[J]. Zhonghua Gan Zang Bing Za Zhi, 2009,17(2):85-87
doi: 10.3760/cma.j.issn.1007-3418.2009.02.002 |
|
范建高 . 2008年脂肪性肝病研究进展[J]. 中华肝脏病杂志, 2009,17(2):85-87
doi: 10.3760/cma.j.issn.1007-3418.2009.02.002 |
|
| [27] |
Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, Huo L, Wang M, Hong J, Wu P, Ren G, Ning G . Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine[J]. J Clin Endocrinol Metab, 2008,93(7):2559-2565
doi: 10.1210/jc.2007-2404 |
| [28] | Xiao FY, Hu AM, Zheng Y, Wang JH . Effects of Tangganjian on glucose-lipid metabolism and transaminase in rats with diabetes mellitus and fatty liver disease[J]. Zhongguo Lao Nian Yi Xue Za Zhi, 2007,27(16):1560-1562 |
| 肖凤英, 胡爱明, 郑云, 王建华 . 糖肝煎对糖尿病性脂肪肝模型大鼠糖脂代谢及氨的影响[J]. 中国老年医学杂志, 2007,27(16):1560-1562 | |
| [29] | He CY, Fu XD, Li B, He YM, Chen WH, Ying J, Wang WJ . Effects of “Yiqi Sanju Formula” on levels of some adipocytokines in central obese men[J]. Shanghai Zhong Yi Yao Za Zhi, 2007,41(8):16-18 |
| 何春燕, 傅晓东, 李玢, 何燕铭, 陈伟华, 应健, 王文健 . 益气散聚方对中心性肥胖男性相关脂肪细胞因子水平的影响[J]. 上海中医药杂志, 2007,41(8):16-18 | |
| [30] |
Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, van Staveren WA . Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project[J]. JAMA, 2004,292(12):1433-1439
doi: 10.1001/jama.292.12.1433 |
| [1] | Di Li, Guan-liang Wang, Meng-ya Shan, Jia-han Liu, Lin Wang, De-zeng Zhu. Effects of ursolic acid on c-Cbl-associated protein expression in 3T3-L1 adipocytes with insulin resistance. Journal of Chinese Integrative Medicine, 2012, 10(8): 886-893. |
| [2] | Dong-mei Zhang, Li-xia Lou, Ai-ming Wu, Xi-ying Lü, Zhao-juan Hu, Yan-hong Zhang, Hong-fang Liu. Effects of Astragalus membranaceus and Potentilla discolor mixture on insulin resistance and its related mRNA expressions in KKAy mice with type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(7): 821-826. |
| [3] | Lin Wang, Guan-liang Wang, Jia-han Liu, Di Li, De-zeng Zhu, Liang-neng Wu . Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ. Journal of Chinese Integrative Medicine, 2012, 10(7): 793-799. |
| [4] | Hong-bo Cao, Hong-cai Shang . Connotations and extensions of comparative effectiveness research and feasibility analysis for clinical evaluation in traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(4): 369-374. |
| [5] | Wang Yun-fei, Que Hua-fa, Xu Jie-nan, Tang Han-jun, Xiang Huan-yu, Liu Xiao-dong, Zhang Zhen, Xing Jie, Shen Liang, Shan Wei, Liu An-min, Qiu Lian-yin, Deng Da-yi, Gao Dan. Assessment of external methods of traditional Chinese medicine in patients with chronic ulcer of the lower extremities: study protocol of a multicenter, randomized, parallel-group, prospective trial. Journal of Chinese Integrative Medicine, 2012, 10(2): 166-175. |
| [6] | You-hua Wang , Shang Li , Bin-rui Yang , Lun-qing Zhang , Xin Zhou , Bei-wen Xu, Ming-yuan Li . Use of zebrafish models for the research of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1189-1197. |
| [7] | Liu Yue, Xie Ming, Zhang Ye. Dynamic changes of laboratory parameters of rats with type 2 diabetes and insulin resistance: defining their role in development of traditional Chinese medicine syndrome. Journal of Chinese Integrative Medicine, 2012, 10(1): 100-108. |
| [8] | Susuana Kuek, Wen-jun Wang, Sui-qi Gui. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2011, 9(9): 965-972. |
| [9] | Xing-jiang Xiong, Jie Wang. Experience of diagnosis and treatment of exogenous high-grade fever. Journal of Chinese Integrative Medicine, 2011, 9(6): 681-687. |
| [10] | Ming Ren, Wei-wei Liu, Zeng-tao Sun, Ji-hong Feng, Hong-cai Shang. Concept and significance of a subjective and multiple index system of clinical evaluation for traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2011, 9(6): 588-591. |
| [11] | Ya Yuwen, Xue-jie Han, Li-ying Wang, Nan-nan Shi, Yong-yan Wang, Ai-ping Lü. Thinking on methods for formulating development strategy of traditional Chinese medicine standardization. Journal of Chinese Integrative Medicine, 2011, 9(5): 483-486. |
| [12] | Hong-ming Nie, Yue-qiu Gao, Jian-jie Chen. Syndrome distribution among patients with chronic hepatitis C and interventions of integrated traditional Chinese and Western medicine: Study protocol. Journal of Chinese Integrative Medicine, 2011, 9(4): 365-373. |
| [13] | Ju-yong Wang, Ling Xu, Rui-xin Zhang, Lixing Lao. Traditional Chinese medicine for cancer pain. Journal of Chinese Integrative Medicine, 2011, 9(2): 129-134. |
| [14] | Li Dong-tao, Li Fu-yu, Wang Jian, Liu Ji-hong, Yan Nan, Cheng Yong-mei, Hu Ai-hua, Jiang Hong-yang, Shi Feng-lei, Zhang Mei-zeng, Li Jie, Wei Ling-bo, Jiang Rong-qin. A study of diagnostic criteria for traditional Chinese medicine syndromes in osteoporosis. Journal of Chinese Integrative Medicine, 2011, 9(12): 1326-1332. |
| [15] | Fa-wei Wang, Li-ping Chen, Jian Hu, Gang Zhang. Use of traditional Chinese medicine during the Red Army period in Chinese history. Journal of Chinese Integrative Medicine, 2011, 9(10): 1145-1149. |
|